Literature DB >> 19747430

The status of asthma control in the U.S. adult population.

Anne Fuhlbrigge1, Michael L Reed, David A Stempel, Hector O Ortega, Kristina Fanning, Richard H Stanford.   

Abstract

Treatment guidelines recognize the importance of achieving and maintaining asthma control. This study was designed to assess the prevalence of asthma control in a representative U.S. population. A survey regarding asthma and associated symptoms was sent to a representative national sample of 134,401 households managed by the National Family Opinion WorldGroup from May to July 2007. Subjects >or=18 years with current asthma were identified and completed the Asthma Control Test (ACT), a brief validated self-administered survey that assesses asthma control. Subjects with an ACT score of >19 have been defined as having well-controlled asthma (WCA) and those with a score of <or=19 were defined as having not well-controlled asthma (NWCA). The prevalence of WCA was identified for the total population as well as subjects who currently were only using albuterol to control asthma symptoms. In addition, the frequency of past asthma exacerbations was studied and correlated with ACT. Surveys were returned by 81,505 households (61% return rate). A total of 10,139 adults self-reported having asthma and completed the ACT. Forty-one percent of these had NWCA and 39% of the subjects using albuterol as the only asthma medication had NWCA. Fifty-eight percent of subjects with NWCA in the total population had an asthma-related exacerbation (asthma-related oral corticosteroid use, emergency department, or hospitalization) in the previous year compared with 24% of subjects with WCA. This large representative national asthma sample using a validated asthma control instrument identified >40% of subjects with NWCA. In addition, subjects using albuterol monotherapy, who would be expected to have mild asthma and thus be well controlled, had a similar high prevalence of NWCA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747430     DOI: 10.2500/aap.2009.30.3276

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  15 in total

Review 1.  Drug development for severe asthma: what are the metrics?

Authors:  Cynthia B Robinson; Joanne Leonard; Reynold A Panettieri
Journal:  Pharmacol Ther       Date:  2012-05-22       Impact factor: 12.310

Review 2.  Asthma outcomes: composite scores of asthma control.

Authors:  Michelle M Cloutier; Michael Schatz; Mario Castro; Noreen Clark; H William Kelly; Rita Mangione-Smith; James Sheller; Christine Sorkness; Stuart Stoloff; Peter Gergen
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

3.  A computerized decision support tool to implement asthma guidelines for children and adolescents.

Authors:  Carolyn M Kercsmar; Christine A Sorkness; Agustin Calatroni; Peter J Gergen; Gordon R Bloomberg; Rebecca S Gruchalla; Meyer Kattan; Andrew H Liu; George T O'Connor; Jacqueline A Pongracic; Stanley J Szefler; Stephen J Teach; Jeremy J Wildfire; Robert A Wood; Edward M Zoratti; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2018-12-05       Impact factor: 10.793

4.  Solving insomnia electronically: Sleep treatment for asthma (SIESTA): A study protocol for a randomized controlled trial.

Authors:  Xiaojun Shi; Daniel J Buysse; Lee M Ritterband; Susan M Sereika; Patrick J Strollo; Sally E Wenzel; Faith S Luyster
Journal:  Contemp Clin Trials       Date:  2019-02-27       Impact factor: 2.226

5.  Occupational exposure to disinfectants and asthma control in US nurses.

Authors:  Orianne Dumas; Aleta S Wiley; Catherine Quinot; Raphaëlle Varraso; Jan-Paul Zock; Paul K Henneberger; Frank E Speizer; Nicole Le Moual; Carlos A Camargo
Journal:  Eur Respir J       Date:  2017-10-05       Impact factor: 16.671

6.  Albuterol Overuse: A Marker of Psychological Distress?

Authors:  Joe K Gerald; Tara F Carr; Christine Y Wei; Janet T Holbrook; Lynn B Gerald
Journal:  J Allergy Clin Immunol Pract       Date:  2015-09-01

7.  Asthma control among adults in Saudi Arabia. Study of determinants.

Authors:  Abdulaziz A BinSaeed
Journal:  Saudi Med J       Date:  2015-05       Impact factor: 1.484

Review 8.  A summary of the new GINA strategy: a roadmap to asthma control.

Authors:  Helen K Reddel; Eric D Bateman; Allan Becker; Louis-Philippe Boulet; Alvaro A Cruz; Jeffrey M Drazen; Tari Haahtela; Suzanne S Hurd; Hiromasa Inoue; Johan C de Jongste; Robert F Lemanske; Mark L Levy; Paul M O'Byrne; Pierluigi Paggiaro; Soren E Pedersen; Emilio Pizzichini; Manuel Soto-Quiroz; Stanley J Szefler; Gary W K Wong; J Mark FitzGerald
Journal:  Eur Respir J       Date:  2015-07-23       Impact factor: 16.671

9.  Role of obesity in asthma control, the obesity-asthma phenotype.

Authors:  Shannon Novosad; Supriya Khan; Bruce Wolfe; Akram Khan
Journal:  J Allergy (Cairo)       Date:  2013-04-24

10.  Electronic health record-based assessment of oral corticosteroid use in a population of primary care patients with asthma: an observational study.

Authors:  Felicia C Allen-Ramey; Linda M Nelsen; Joseph B Leader; Dione Mercer; Henry Lester Kirchner; James B Jones
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-07       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.